AMG 193 + Other Therapies in Advanced GI & PDAC with homozygous MTAP-deletion (20230223) - Clinical Trial

¿Quién puede participar en el Estudio?

Grupo etario

Adultos

Detalles del Estudio

Título Completo

A Phase 1b Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of AMG 193 in Combination With other Therapies in Subjects With Advanced Gastrointestinal, Biliary Tract, or Pancreatic Cancers With Homozygous MTAP-deletion Master Protocol (20230223)

Investigador Principal